Biotechnology News

April 9, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus reported financial results for its 2nd quarter of fiscal year 2014. Net sales were $3.081 million & gross profit $2.589 million for the Company's 26th consecutive profitable quarter.

April 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Spero Therapeutics partners with Roche to develop drugs for drug resistant bacterial infections

April 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the presentation of scientific data at the American...

April 9, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--RBCC and n3D Seek Out Additional Capital

April 9, 2014

NEW YORK & BARCELONA, Spain--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM:MC) today announced that they have recently received feedback from the U.S. Food and Drug Administration (FDA) regarding the fixed dose...

April 9, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Pink Sheets IPSEY) (Euronext: IPN; ADR: IPSEY) today confirmed its eligibility for the PEA-PME scheme, in accordance with the French decree n° 2014-283 of 4 March 2014. The Group...

April 9, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet...

April 8, 2014

PRINCE WILLIAM COUNTY, Va.--(BUSINESS WIRE)--Prince William County, Virginia today welcomed ISOThrive, a start-up life sciences company, as the first tenant of the Prince William Science Accelerator.

April 8, 2014

WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced the first findings from...

April 8, 2014

ATLANTA--(BUSINESS WIRE)--Round2Funding invites early stage healthcare Companies to apply for their exclusive Pitch Competition to be held May 17th at the Georgia Tech Conference Center in front of several of Investors.

April 8, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it plans to appoint Paul N. Clark and James G. Cullen to the board of directors of Keysight Technologies, Inc. Clark is expected to become Keysight’s...

April 8, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics (Mirna), a private, clinical stage biopharmaceutical company focused on the development of microRNA-based oncology therapeutics, today announced interim safety data from a multicenter, open-label...

April 8, 2014

TEANECK, N.J.--(BUSINESS WIRE)--Arxspan Introduces Service Integrating SAFE-BioPharma Digital Signatures into Any Existing Application

April 8, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--The Tech Council of Maryland praised state lawmakers for advancing key priorities for the tech community during this year’s legislative session.

April 8, 2014

PHOENIX--(BUSINESS WIRE)--Arizona’s Bioscience Roadmap, the strategic plan that has guided Arizona’s fast-growing bioscience sector for nearly 12 years, is gearing up for a new decade with updated goals and strategies.

April 8, 2014

SAN DIEGO--(BUSINESS WIRE)--NIH Center for Regenerative Medicine Founding Director Dr. Mahendra Rao joins Stemedica's Scientific and Medical Advisory Board.

April 8, 2014

SAN DIEGO--(BUSINESS WIRE)--The European Centre for Clinical Research Training (ECCRT), a SynteractHCR company, has been recognized by TransCelerate BioPharma Inc. as an official training facility meeting high standards.

April 8, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs, a premier independent provider of professional forensic and clinical laboratory services, has announced the promotion of two key individuals on its executive leadership team. William S. Hough, Jr.,...

April 8, 2014

HORSHAM, England--(BUSINESS WIRE)--Cmed has been invited to share its early phase clinical research expertise at leading industry events in the coming months.

April 8, 2014

LOS ANGELES--(BUSINESS WIRE)--HemaCare, a leading provider of cellular therapy services to healthcare providers and the scientific community, to host expert panel on cell therapy at ISCT 2014 (Paris, April 23-26).

April 8, 2014

WASHINGTON & BELO HORIZONTE, BRAZIL--(BUSINESS WIRE)--BIO and Biominas Brasil today announced that they will co-host the inaugural BIO Latin America Conference to be held September 9 through September 11, 2014 in Rio de Janeiero, Brazil.

April 8, 2014

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of Jimmy...

April 8, 2014

BEND, Ore.--(BUSINESS WIRE)--Innovator in Solubilization Formulation Expands Board of Directors for Next Chapter of Growth, Adds Small-Cap Investment Expert

April 8, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Tal Wenderow, Co-founder and EVP of Product & Business Development of Corindus, will present at the upcoming...

April 8, 2014

SAN CLEMENTE, Calif. & SHANGHAI--(BUSINESS WIRE)--ReFlow Medical enters into a partnership with leading Chinese medical device company

April 8, 2014

PITTSBURGH--(BUSINESS WIRE)--Positive clinical trial results of a topical botulinum toxin formulation for overactive bladder (OAB) are presented.

April 8, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it will receive milestone payments from Takeda Pharmaceutical Company Limited (Takeda) totaling $6 million as a result of achieving the first commercial...

April 8, 2014

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Edge Therapeutics today announced the appointment and promotion of key executives to its senior management team to strengthen the Company’s leadership.

April 8, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the approval of the generic equivalent to Lovaza® (Omega-3-Acid Ethyl Esters Capsules, USP), in the United States. Teva believes it is first-to-file and thus...

April 8, 2014

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist received a Class 4 medical device license from Health Canada for the TandemHeart System to provide up to 10 days of percutaneous circulatory support for patients in cardiac distress.

April 8, 2014

TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device

April 8, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One announced an agreement with Dartmouth-Hitchcock Medical Center in Lebanon, NH to provide clinical interpretation for Dartmouth-Hitchcock’s Next-Generation Sequencing tests.

April 8, 2014

BERLIN--(BUSINESS WIRE)--NOXXON Pharma announced today that their anti-Hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) increases hemoglobin in subset of anemic patients in pilot phase IIa study.

April 8, 2014

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--MindChild Medical, Inc. today announced that the MERIDIAN Non-Invasive Fetal Heart Rate Monitor successfully completed it’s 1,000th non-invasive fetal heart monitoring session. Five separate health care...

April 8, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Showcase Urological Products at the European Association of Urology's 29th Annual Congress

April 8, 2014

SAN JOSE, Calif.--(BUSINESS WIRE)--HighTech Business Decisions publishes new report on the mammalian cell culture media market for biopharmaceutical production.

April 8, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated...

April 8, 2014

BRISBANE & THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has strengthened its board of...

April 8, 2014

TOKYO--(BUSINESS WIRE)--PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)( TOKYO:4587) announced today, in collaboration with The Tokyo Metropolitan Institute of Medical Science (“Tokyo Metropolitan Institute”) the...

April 8, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate) for the treatment of...

April 7, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at...

April 7, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today that it has launched Deerfield Private Design Fund III, an investment fund designed to provide flexible private financing to healthcare companies. The fund has approximately...

April 7, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals Announces Proposed Public Offering of Common Stock

April 7, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announces the date of its first-quarter 2014 earnings release and conference call. The conference call will be held on May 1, 2014 at 9:00am EDT.

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today presented new preclinical data demonstrating the ability of its Toll-like receptor (TLR) antagonist, IMO-8400, to inhibit the survival and proliferation of B-cell...

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND presents clinical data demonstrating differentiating attributes of BIND-014 administered with a weekly dosing schedule which may enable increased dose intensity and enhanced therapeutic efficacy